Cy5.5 NHS Ester for NIR Biomolecule Tracking

Near-infrared labeling is most useful when it answers a specific biological question: where does a biomolecule go, how long does it remain detectable, and does the labeling process change its behavior? Cy5.5 NHS ester (non-sulfonated) is designed for that type of workflow. Its NHS ester reacts with accessible primary amines on proteins, peptides, and amino-functionalized oligonucleotides to form stable amide bonds, enabling covalent tracking rather than transient dye association.

The reagent is particularly suited to near-infrared fluorescence imaging because its reported excitation maximum is approximately 684 nm and its emission maximum is near 710 nm. The product information also reports an extinction coefficient of 209,000 M^-1cm^-1 and a quantum yield of 0.2, characteristics that support sensitive detection when labeling density, optical filters, and background controls are properly managed. APExBIO supplies the product as a solid for light-protected storage at -20 °C.

Setup and principle overview

How the conjugation chemistry works

Cy5.5 NHS ester is an amino group labeling reagent. The NHS ester is most reactive toward unprotonated primary amines, so conjugation is generally favored in a mildly basic, amine-free buffer. The resulting amide bond is stable under typical purification and imaging conditions, whereas unreacted dye remains a major source of background and must be removed.

The non-sulfonated form has low aqueous solubility. According to the product information, it dissolves in organic solvents such as DMF and DMSO, with reported DMSO solubility of at least 35.82 mg/mL. Prepare a concentrated organic stock immediately before use, then add it gradually to the aqueous biomolecule solution. Directly placing dry dye into an aqueous reaction often produces particles, uneven labeling, and misleadingly high apparent fluorescence.

Because the dye absorbs and emits in the near-infrared range, it can reduce some visible-range autofluorescence and is compatible with many whole-animal and tissue imaging platforms. However, near-infrared fluorescence imaging is not background-free: blood, tissue thickness, illumination geometry, detector sensitivity, and dye accumulation all affect the result. A labeled sample should therefore be compared with an unlabeled biological matrix and a free-dye control.

Key Innovation from the Reference Study

The reference study on Oudemansiella raphanipies polysaccharides used ultrasonic-assisted extraction combined with response surface methodology rather than treating extraction as a single fixed-variable experiment. In the published report, the optimized condition was 55 °C for 90 minutes at 250 W with a 1:60 g/mL solid-to-liquid ratio, producing an extraction yield of 210.35 ± 0.20 mg/g. The purified fraction, designated UAE-ORP, had a reported molecular weight of 568.57 kDa and was mainly composed of glucose at 35.48% and galactose at 28.51%. These findings are described in the Food Chemistry: X reference study.

The important imaging insight was not simply that the polysaccharide could be extracted efficiently. The investigators used near-infrared imaging to follow distribution in vivo and reported prominent gastrointestinal localization, with intestinal retention for as long as 24 hours. For a labeling scientist, this suggests a practical decision tree. If the experimental question concerns residence time or gastrointestinal distribution, prioritize a low-disturbance labeling strategy and confirm that the fluorescent tag remains associated with the polysaccharide preparation. If the goal is to compare fractions, normalize the signal to recovered material rather than comparing raw fluorescence alone.

UAE-ORP is a carbohydrate-rich material and is not automatically an ideal direct substrate for an NHS ester. Carbohydrates generally do not present the same abundance of accessible primary amines as proteins. Therefore, using Cy5.5 NHS ester to track this type of polysaccharide requires a validated amine-bearing handle or an amine-containing carrier strategy; the dye should not be assumed to label the native polysaccharide efficiently without characterization. This distinction translates the paper into a better assay choice rather than incorrectly claiming that the reference study validated this specific reagent.

Why this cross-domain matters, maturity, and limitations

The bridge from mushroom-polysaccharide extraction to fluorescent biomolecule conjugation is useful because it links material preparation, biological distribution, and optical readout. It is also an adaptation across domains. The reference study supports the extraction parameters, physicochemical characterization, bioactivity assays, and NIR distribution result; it does not establish that Cy5.5 NHS ester (non-sulfonated) was the labeling reagent or that NHS chemistry preserves every ORP function.

Amine-reactive protein labeling is a mature and broadly transferable workflow. Applying it to a high-molecular-weight polysaccharide is less mature and should be treated as method development. Confirm labeling stoichiometry, molecular-weight distribution, fluorescence stability, recovery after purification, and whether the conjugate retains the water-retention, antioxidant, or prebiotic properties being investigated. The optical signal should be interpreted as distribution evidence only after chemical association and biological controls are demonstrated.

Step-by-step labeling workflow

Protocol Parameters

• Stock preparation: Dissolve the solid at 1-10 mM in anhydrous DMSO or DMF at 20-25 °C, protect from light, and use the freshly prepared solution within 2 hours as a practical starting condition.
• Biomolecule solution: Prepare protein or peptide at 0.5-2 mg/mL in an amine-free buffer adjusted to pH 8.3-8.5; keep the aqueous reaction volume sufficient to mix without visible precipitation.
• Dye addition: Add a 3-10 molar excess of Cy5.5 NHS ester over accessible primary amines while mixing at 20-25 °C; begin with a 30-60 minute reaction and shield the tube from light.
• Organic cosolvent: Start at 1-5% v/v DMSO in the final reaction and keep the same cosolvent percentage in matched controls so that signal differences are not confused with solvent effects.
• Cleanup and storage: Remove free dye by a validated desalting or size-exclusion step, collect fractions at 4 °C, and use the purified conjugate promptly rather than storing an aqueous dye solution for extended periods.

These are executable starting parameters for optimization, not a substitute for a molecule-specific validation study. The number of accessible amines varies with sequence, folding, concentration, and buffer composition. For a protein with many lysines, a high dye-to-protein ratio can produce bright material but may also increase aggregation or impair binding. A small pilot series using 3-, 5-, and 10-fold molar excess is often more informative than committing an entire sample to one condition.

Workflow enhancements for reproducibility

1. Plan the labeling ratio first. Estimate the number of accessible amines and define whether the experiment needs maximum brightness or minimal perturbation. For receptor, enzyme, or antibody studies, low-to-moderate substitution is generally the safer initial design.
2. Control pH and buffer composition. Avoid Tris, glycine, ammonium-containing buffers, or other primary-amine-containing components during the reaction because they can consume NHS ester. Exchange into a compatible buffer before adding the dye.
3. Make addition geometry consistent. Add the organic dye stock slowly to the stirred or gently mixed aqueous sample. Record stock concentration, addition volume, reaction pH, time, temperature, and light exposure for every batch.
4. Separate chemistry from imaging. After purification, quantify protein or nucleic-acid concentration independently from fluorescence. Calculate a dye-to-biomolecule ratio using the appropriate absorbance correction for the dye and the biomolecule, then compare equal biomolecule amounts on the imaging platform.
5. Validate association. Use size-exclusion chromatography, electrophoretic mobility, or another orthogonal method to distinguish covalently labeled material from free Cy5.5. For a polysaccharide application, also compare the labeled preparation with an unlabeled preparation for size and functional behavior.

Advanced applications and comparative advantages

Protein, peptide, and oligonucleotide tracking

As a fluorescent dye for protein conjugation, Cy5.5 NHS ester can support uptake studies, biodistribution experiments, binding assays, and microscopy where a red-shifted signal is advantageous. Peptides can be labeled when they contain an accessible N-terminal or side-chain amine. Oligonucleotides and plasmid DNA require special attention: native nucleic acids may not provide a convenient population of primary amines, so an amino-functionalized design or validated post-synthetic handle is usually needed.

The product dossier also identifies plasmid-DNA labeling and optical imaging, including preclinical optical imaging of tumors, as relevant use cases. In vivo fluorescence imaging can then be used to compare localization between treatment groups, but fluorescence intensity should not be interpreted directly as molecule concentration unless tissue attenuation, exposure settings, recovery, and labeling degree are controlled.

Why the near-infrared window helps

Excitation near 684 nm and emission near 710 nm place the signal in a useful red-to-near-infrared region. The high reported extinction coefficient can support detection of dilute conjugates, while the quantum yield of 0.2 indicates that brightness still depends strongly on instrument configuration and dye microenvironment. Compared with visible dyes, this spectral placement may improve contrast in some tissue and cell formats, but it does not eliminate quenching from excessive labeling or nonspecific retention of free dye.

How this guide extends related workflows

The earlier scenario-based Cy5.5 NHS ester guide complements this article by focusing on cell viability, proliferation, and cytotoxicity workflows. Its assay-centered perspective is useful after conjugation, whereas the present guide emphasizes reagent handling, amine accessibility, and distribution studies. For translational design, the near-infrared imaging strategy article extends the discussion toward deep-tissue and real-time imaging; it should be read as an application context rather than evidence that every proposed imaging platform has been validated with this NHS ester.

Troubleshooting and optimization tips

Precipitation or cloudy reaction mixture

The most likely causes are poor dissolution, excessive local dye concentration, or insufficient compatibility between the organic stock and aqueous buffer. Prepare the stock at a lower concentration, allow complete dissolution before addition, and add it slowly. Keep the final DMSO level consistent across samples. If turbidity persists, reduce the dye-to-amine ratio and test a smaller reaction volume before scaling up.

Weak fluorescence after purification

Check whether the free dye was removed too aggressively, whether the conjugate was over-diluted, and whether the imaging instrument is configured for approximately 684 nm excitation and 710 nm emission. Confirm the conjugate concentration independently and include a known bright reference. Weak signal can also reflect hydrolysis of the NHS ester before it contacts the biomolecule, so shorten the interval between stock preparation and dye addition.

High background or broad imaging signal

Residual free dye is a common explanation. Extend or repeat the cleanup step, collect and test individual fractions, and image a free-dye control processed through the same buffer and purification workflow. In animal studies, include an unlabeled-material control and keep acquisition settings identical between groups. The reference study's intestinal retention observation makes this especially important for gastrointestinal experiments, where luminal signal and true biological association may otherwise be confused.

Loss of biological activity

Over-labeling can alter charge, steric accessibility, folding, binding, or uptake. Compare at least two labeling ratios, measure the relevant functional endpoint before and after conjugation, and use the lowest dye loading that provides adequate signal. For ORP-like preparations, test molecular-weight distribution and the functional property of interest after labeling; a bright image does not prove that the polysaccharide remains chemically or biologically equivalent.

Batch-to-batch variability

Record dye lot, stock age, solvent, pH, temperature, reaction time, purification recovery, and degree of labeling. Store the solid at -20 °C in the dark and minimize repeated light exposure, consistent with the product specifications. Do not rely on long-term storage of prepared aqueous solutions; make fresh working solutions for critical experiments.

Future outlook

The reference study shows how optimized extraction and NIR distribution analysis can turn a complex food-derived polysaccharide into a testable functional material. The next defensible step is not simply brighter imaging, but a validated chain of evidence connecting labeling chemistry, recovered conjugate, gastrointestinal localization, and retained function. Cy5.5 NHS ester (non-sulfonated) can contribute to that chain when an accessible amine handle is present and when free dye, tissue background, and labeling-induced changes are explicitly controlled.

For biomolecule tracking, the strongest future workflows will combine spectral calibration with orthogonal chemical and functional assays. That approach preserves the central finding of the reference study—extended intestinal distribution can be visualized—while making the optical readout more quantitative, reproducible, and useful for comparing preparations or delivery strategies.